Back to search

Article

Brain volume loss in relapsing multiple sclerosis: Indirect treatment comparisons of available disease-modifying therapies

2023-11-20

Abstract excerpt

<title>Abstract</title> <p>Background Brain volume loss (BVL) has been identified as a predictor of disability progression in relapsing multiple sclerosis (RMS). As many available disease-modifying treatments (DMTs) have shown an effect on slowing BVL, this is becoming an emerging clinical endpoint in RMS clinical trials. Methods In this study, a systematic literature review was conducted to identify BVL result...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a7f690f3-e7ea-5044-85df-c71e0cebb0c8
DOI
10.21203/rs.3.rs-3611288/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Brain volume loss in relapsing multiple sclerosis: Indirect treatment comparisons of available disease-modifying therapiesDOI 10.21203/rs.3.rs-3611288/v1
Deep grey matter volume loss drives disability worsening in multiple sclerosisSemantic proximity
Disease-modifying therapies for T1 hypointense lesions (Black Holes) volume in patients with multiple sclerosis: Protocol for a systematic review and meta-analysisSemantic proximity
Interval reduction in MRI lesion burden in relapsing-remitting multiple sclerosis following an integrative alternative medicine regimen: a case reportSemantic proximity
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.Semantic proximity
Normative Modelling of Brain Volume for Diagnostic and Prognostic Stratification in Multiple SclerosisSemantic proximity
Therapeutic Efficacy and Safety of Deep Brain Stimulation for Multiple Sclerosis Related-Tremor: A Systematic Review and Meta-AnalysisSemantic proximity
Trigeminal Neuralgia in Multiple Sclerosis: A Critical Review of the Therapeutic Evidence and the Role of Cerebellopontine Angle Surgical ExplorationSemantic proximity
Quantifying MS Progression in the Era of Highly Effective Therapy: Trial Design ImplicationsSemantic proximity
Comparative effectiveness of natalizumab and fingolimod and injectable therapies in patients with pediatric multiple sclerosis: A registry-based retrospective cohort studySemantic proximity
White Matter Volume and Microstructural Integrity Are Associated with Fatigue in Relapsing Multiple SclerosisSemantic proximity
Optimal Clinical Trials Platform for Progressive Multiple Sclerosis (OCTOPUS): protocol for an international, multi-arm, multi-stage, platform, randomized controlled, double-blind, phase 3 clinical trialSemantic proximity
MultiSCRIPT-Cycle 1- A Pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in Multiple Sclerosis: a study protocol for a randomized clinical trialSemantic proximity
Select a neighboring publication to make it the new centre.